1 INDICATIONS AND USAGE Riluzole tablets are indicated for the treatment of amyotrophic lateral sclerosis (ALS). Riluzole tablets are indicated for the treatment of amyotrophic lateral sclerosis (ALS) ( 1 )
glenmark pharmaceuticals inc., usa
16 HOW SUPPLIED/STORAGE AND HANDLING
RILUZOLE tablets USP, 50 mg are white to off-white, capsule shaped, beveled edged, film-coated tablets, engraved with â€˜381â€™ on one side and â€˜Gâ€™ on the other side.
RILUZOLE tablets USP, 50 mg are supplied in: Bottles of 60 tablets NDC 68462-381-60 Bottles of 1000 tablets NDC 68462-381-10 Store at 20Â°C to 25Â°C (68Â°F to77Â°F) [see USP Controlled Room Temperature] and protect from bright light. Keep out of the reach of children.
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site